Association of asymptomatic cerebral vasospasm with outcomes in survivors of aneurysmal subarachnoid hemorrhage

被引:4
作者
Shamshad, Alizeh
Persad-Paisley, Elijah M.
Wendell, Linda C. [2 ]
Thompson, Bradford B. [1 ,3 ,4 ]
Reznik, Michael E. [1 ,3 ,4 ]
Furie, Karen L. [3 ]
Mahta, Ali [1 ,3 ,4 ,5 ,6 ]
机构
[1] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA
[2] Mt Auburn Hosp, Div Neurol, Cambridge, MA USA
[3] Brown Univ, Rhode Island Hosp, Warren Alpert Med Sch, Dept Neurol, Providence, RI 02912 USA
[4] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Neurosurg, Providence, RI 02912 USA
[5] Brown Univ, Sect Med Educ, Warren Alpert Med Sch, Providence, RI 02912 USA
[6] Brown Univ, RhodeIsland Hosp, Warren Alpert Med Sch, Div Neurocrit Care, 593 Eddy St, APC-712-6, Providence, RI 02903 USA
关键词
Vasospasm; Subarachnoid hemorrhage; Aneurysm; Asymptomatic; Outcome; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; SYMPTOMATIC VASOSPASM; THERAPY; MANAGEMENT; ISCHEMIA;
D O I
10.1016/j.jstrokecerebrovasdis.2022.106821
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Cerebral vasospasm (cVSP) is a common complication in aneurysmal subarachnoid hemorrhage (aSAH) and is associated with worse outcomes. How-ever, clinical significance of asymptomatic cVSP is poorly understood. We sought to determine the association of asymptomatic cVSP with functional outcome and hospital length of stay (LOS). Methods: We performed a retrospective study of a pro-spectively collected cohort of patients with aSAH who survived hospitalization at an academic center between 2016 and 2021. We defined cVSP based on transcranial Doppler criteria. Multivariate logistic and multiple linear regression analyses were used to determine the association of asymptomatic cVSP with poor functional out-come (defined as modified Rankin scale 3-6 at 3 months after discharge) and hospi-tal length of stay (LOS). Results: The cohort consisted of 201 aSAH patients with a mean age 54.9 years (SD 13.6) and 60% were female. One hundred nine patients (54%) experienced cVSP, of whom 43 patients (39%) were asymptomatic. Patients with asymptomatic cVSP were younger (mean 50.5 years [SD 10.6] vs 61 years [SD12.5]; p < 0.001) and had longer ICU LOS (median 13 days [IQR12-20] vs median 12 days [IQR9-15], p = 0.018) compared to those without cVSP. However, after adjusting with other variables asymptomatic cVSP was not associated with longer ICU or hospital LOS. Asymptomatic cVSP was not associated with poor out-come either (p = 0.14). Conclusion: Asymptomatic cVSP, which was more common in younger patients, was neither associated with poor functional outcome nor hos-pital LOS. Larger prospective studies are needed to assess the significance of asymptomatic cVSP on long-term outcomes.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Magnesium Sulfate Therapy for Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
    Akdemir, Hidayet
    Kulaksizoglu, E. Onur
    Tucer, Buelent
    Menkue, Ahmet
    Postalci, Luetfue
    Guenaldi, Oemuer
    NEUROSURGERY QUARTERLY, 2009, 19 (01) : 35 - 39
  • [42] How is vasospasm screening using transcranial Doppler associated with delayed cerebral ischemia and outcomes in aneurysmal subarachnoid hemorrhage?
    M. Hollingworth
    A. A. B. Jamjoom
    D. Bulters
    H. C. Patel
    Acta Neurochirurgica, 2019, 161 : 385 - 392
  • [43] DOES THROMBIN PREVENT CEREBRAL VASOSPASM FOLLOWING ANEURYSMAL SUBARACHNOID HEMORRHAGE
    ONEILL, P
    WALTON, S
    FOY, PM
    SHAW, MDM
    BRITISH JOURNAL OF NEUROSURGERY, 1992, 6 (04) : 313 - 320
  • [44] Precision medicine of aneurysmal subarachnoid hemorrhage, vasospasm and delayed cerebral ischemia
    Burrell, Christian
    Avalon, Nicole E.
    Siegel, Jason
    Pizzi, Michael
    Dutta, Tumpa
    Charlesworth, M. Cristine
    Freeman, William D.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (11) : 1251 - 1262
  • [45] Smartphone pupillometry for detection of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
    Maxin, Anthony J.
    Kush, Sophie
    Gulek, Bernice G.
    Winston, Graham M.
    Chae, John
    Shaibani, Rami
    McGrath, Lynn B.
    Abecassis, Isaac J.
    Levitt, Michael R.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (10)
  • [46] Perfusion CT to quantify the cerebral vasospasm following subarachnoid hemorrhage
    Lefournier, Virginie
    Krainik, Alexandre
    Gory, Benjamin
    Derderian, Frederic
    Bessou, Pierre
    Fauvage, Bertrand
    Le Bas, Jean-Francois
    Payen, Jean-Francois
    JOURNAL OF NEURORADIOLOGY, 2010, 37 (05) : 284 - 291
  • [47] Haptoglobin Phenotype Predicts Cerebral Vasospasm and Clinical Deterioration after Aneurysmal Subarachnoid Hemorrhage
    Ohnishi, Hiroyuki
    Iihara, Koji
    Kaku, Yasuyuki
    Yamauchi, Keita
    Fukuda, Kenji
    Nishimura, Kunihiro
    Nakai, Michikazu
    Satow, Tetsu
    Nakajima, Norio
    Ikegawa, Masaya
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2013, 22 (04) : 520 - 526
  • [48] Intraarterial Nimodipine Infusion to Treat Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage
    Kim, Jong Hoon
    Park, In Sung
    Park, Kyung Bum
    Kang, Dong-Ho
    Hwang, Soo Hyun
    JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2009, 46 (03) : 239 - 244
  • [49] Multiplexed protein profiling after aneurysmal subarachnoid hemorrhage: Characterization of differential expression patterns in cerebral vasospasm
    Walcott, Brian P.
    Patel, Anoop P.
    Stapleton, Christopher J.
    Trivedi, Rikin A.
    Young, Adam M. H.
    Ogilvy, Christopher S.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2014, 21 (12) : 2135 - 2139
  • [50] Intra-arterial Dantrolene for Refractory Cerebral Vasospasm After Aneurysmal Subarachnoid Hemorrhage
    Majidi, Shahram
    Grigoryan, Mikayel
    Tekle, Wondwossen G.
    Qureshi, Adnan I.
    NEUROCRITICAL CARE, 2012, 17 (02) : 245 - 249